当前位置:药药网 / 数据中心 /变体注释摘要_体外和功能分析类型
三磷酸吉西他滨二三乙胺-gemcitabine triphosphate ditriethylamine
药物名称(英)
gemcitabine triphosphate ditriethylamine
记事
Gemcitabine, gemcitabine triphosphate (dFdCTP), and de-aminated gemcitabine (dFdU) plasma concentrations were measured before (5, 15, 30, 45 min) and after gemcitabine infusion (1, 1.25, 1.5, 2, 6, 24, 48, 72 hrs). Population pharmacokinetic analysis of gemcitabine and metabolites (dFdU, dFdCTP) were performed by non-linear mixed effects modeling. Pharmacokinetics of dFdCTP were described by a three-compartment model. SLC28A3 rs7867504 genotype was associated with formation of dFdCTP, a pharmacologically active metabolite of gemcitabine. The CC genotype was associated with a 1.77 fold increase in formation of dFdCTP (gemcitabine triphosphate).
专家论述
Genotype CC is associated with increased formation of gemcitabine triphosphate ditriethylamine.